Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-3037

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70518-3037). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Atorvastatin Calcium 20 mg film-coated tablets packaging label with a quantity of 30 tablets. The label shows the product name, strength, dosage form, and quantity on the left side. The right side includes NDC number 70518-3037-00, manufacturer information (Ascend Labs, LLC, Montvale, NJ), storage instructions, and repackaging information by RemedyRepack Inc. The label includes a QR code and a notice to keep medication out of reach of children.*

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

A line graph depicting cumulative incidence (%) over time in years, comparing Atorvastatin and placebo groups. The Atorvastatin group's incidence rises more slowly than the placebo's, indicating a lower cumulative incidence. The graph includes a hazard ratio (HR) of 0.64 with confidence interval (0.50-0.83) and a p-value of 0.0005.*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

A Kaplan-Meier plot showing cumulative hazard percentage over time to first primary endpoint through four years of follow-up. The graph compares Atorvastatin and placebo groups, with the Atorvastatin group having a lower cumulative hazard throughout the period, indicated by solid and dashed lines respectively, along with a hazard ratio (HR) of 0.63 and a p-value of 0.001.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

A line graph showing the percentage of subjects experiencing an event over time in years, comparing Atorvastatin 10 mg (dashed line) and Atorvastatin 80 mg (solid line). The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis represents subjects (%) experiencing the event. A hazard ratio (HR) of 0.78 with confidence interval (0.69-0.89) and p-value 0.0002 are noted on the graph.*

FDA Label Image

Atorvastatin-st (Atorvastatin St)

Chemical structure of Atorvastatin Calcium dihydrate shown in a molecular diagram, depicting the arrangement of its atoms including phenyl rings, hydroxyl groups, fluorine substitution, and calcium ion complexation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.